Doris Matsui (D-CA)

Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026.

H.R. 8143 · House bill Health

A Democratic bill with 1 Republican cosponsor · See all 2 cosponsors

Last activity — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

The "Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026" amends the Social Security Act regarding Medicare part D prescription drug plans. Starting January 1, 2027, it requires plan sponsors using a formulary to place certain generic drugs and at least two biosimilar biological products in a preferred position if their wholesale acquisition cost is lower than the reference product. It also prohibits plan sponsors from placing more restrictive access limits on these lower-cost options than those placed on the reference drugs.

Yes· 3 of 17

  • Scored +9

    Would people over 65 be better off under this?

    Directly targets Medicare Part D enrollees by reducing their out-of-pocket prescription drug costs.

  • Scored +9

    Would retired people be better off under this?

    Directly benefits retirees who utilize Medicare Part D for prescription drug coverage.

  • Scored +8

    Does this lower the price of prescription medicines?

    Directly mandates the preferred placement of lower-cost generics and biosimilars to reduce patient out-of-pocket costs.

The opposite

No question was scored the opposite.